Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Takeda_Pharmaceutical_Company
|
| gptkbp:acquisitionYear |
2021
|
| gptkbp:country |
gptkb:United_Kingdom
|
| gptkbp:focusesOn |
gamma delta T cell therapies
|
| gptkbp:foundedIn |
2016
|
| gptkbp:founder |
Adrian Hayday
Oliver N. Siegel |
| gptkbp:headquartersLocation |
gptkb:London
|
| https://www.w3.org/2000/01/rdf-schema#label |
GammaDelta Therapeutics
|
| gptkbp:specializesIn |
oncology
immunotherapy |
| gptkbp:website |
https://gammadeltatx.com
|
| gptkbp:bfsParent |
gptkb:Takeda
|
| gptkbp:bfsLayer |
6
|